We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 22 JULY 2011
Drug Pricing & Reimbursement @ Gowlings - July 20, 2011

Gowling WLG
Contributor

Gowling WLG
The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...
View firm profileThe Federal Court, in a July 12, 2011 decision, in the case of Sanofi Pasteur Limited v. Attorney General of Canada 2011 FC 859 (T-83-10) ("Sanofi"), declared a decision of the Patented Medicines Price Review Board ("Board") to be null and void, and required the Board to return amounts paid by Sanofi pursuant to the Board’s order, and directing the matter back for reconsideration.
CanadaIntellectual Property



